Myc Recruits P-TEFb to Mediate the Final Step in the Transcriptional Activation of the Cad Promoter
Overview
Authors
Affiliations
The c-Myc protein is up-regulated in many different types of cancer, suggesting that a detailed understanding of Myc function is an important goal. Our previous studies have focused on determining the mechanism by which Myc activates transcription using the target gene cad as an experimental model. Previously, we found that Myc activates cad transcription at a post-RNA polymerase II recruitment step and that the Myc transactivation domain interacts with a number of cdk-cyclin complexes. We now extend these studies to determine the role of these cyclin-cdk complexes in Myc-mediated transactivation. We have found that cyclin T1 binding to Myc localizes to the highly conserved Myc Box I, whereas cdk8 binding localizes to the amino-terminal 41 amino acids of the Myc transactivation domain. We showed that recruitment of cdk8 is sufficient for activation of a synthetic promoter construct. In contrast, the ability of Myc to activate transcription of the cad promoter correlates with binding of cyclin T1. Furthermore, recruitment of cyclin T1 to the cad promoter via a Gal4 fusion protein or through protein-protein interaction with the HIV-1 Tat protein can also activate cad transcription. These results suggest that Myc activates transcription by stimulating elongation and that P-TEFb is a key mediator of this process.
Transcriptional regulation by MYC: an emerging new model.
Jakobsen S, Siersbaek R Oncogene. 2024; 44(1):1-7.
PMID: 39468222 DOI: 10.1038/s41388-024-03174-2.
Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal.
Cisneros W, Soliman S, Walter M, Simons L, Cornish D, De Fabritiis S PLoS Pathog. 2024; 20(9):e1012083.
PMID: 39259751 PMC: 11419360. DOI: 10.1371/journal.ppat.1012083.
MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer.
Meena J, Wang J, Neill N, Keough D, Putluri N, Katsonis P Cancer Discov. 2024; 14(9):1699-1716.
PMID: 39193992 PMC: 11372365. DOI: 10.1158/2159-8290.CD-22-0649.
Vidal R, Leen E, Herold S, Muller M, Fleischhauer D, Schulein-Volk C Elife. 2024; 13.
PMID: 39177021 PMC: 11343564. DOI: 10.7554/eLife.94407.
Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal.
Cisneros W, Walter M, Soliman S, Simons L, Cornish D, Halle A bioRxiv. 2024; .
PMID: 38464055 PMC: 10925308. DOI: 10.1101/2024.03.01.582881.